|
TAF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.46560000048002E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.64250000000466E-05 |
| Normal-vs-Stage2 |
2.988300E-02 |
| Normal-vs-Stage3 |
5.9894999999921E-05 |
| Normal-vs-Stage4 |
4.16030000000012E-05 |
| Stage1-vs-Stage2 |
5.591000E-01 |
| Stage1-vs-Stage3 |
4.401000E-01 |
| Stage1-vs-Stage4 |
2.959000E-01 |
| Stage2-vs-Stage3 |
3.153400E-01 |
| Stage2-vs-Stage4 |
2.332400E-01 |
| Stage3-vs-Stage4 |
8.400400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.00159999996785E-06 |
| Normal-vs-AfricanAmerican |
1.23610000013485E-07 |
| Normal-vs-Asian |
7.298400E-01 |
| Caucasian-vs-AfricanAmerican |
5.174100E-02 |
| Caucasian-vs-Asian |
6.688100E-02 |
| AfricanAmerican-vs-Asian |
9.463800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.92340000055347E-07 |
| Normal-vs-Female |
1.173730E-04 |
| Male-vs-Female |
4.650400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.962510E-03 |
| Normal-vs-Age(41-60Yrs) |
1.402690E-04 |
| Normal-vs-Age(61-80Yrs) |
9.7797999998317E-07 |
| Normal-vs-Age(81-100Yrs) |
9.793200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.489400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.890400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.921600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.452200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.957200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.482800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.387600E-01 |
| Normal-vs-Grade 2 |
5.807200E-04 |
| Normal-vs-Grade 3 |
3.22739999947252E-07 |
| Normal-vs-Grade 4 |
2.32969999999222E-05 |
| Grade 1-vs-Grade 2 |
2.255200E-01 |
| Grade 1-vs-Grade 3 |
2.482400E-02 |
| Grade 1-vs-Grade 4 |
4.925900E-02 |
| Grade 2-vs-Grade 3 |
5.274100E-02 |
| Grade 2-vs-Grade 4 |
4.396000E-02 |
| Grade 3-vs-Grade 4 |
4.376200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.719700E-03 |
| Normal-vs-ccB subtype |
2.048600E-04 |
| ccA subtype-vs-ccB subtype |
2.967400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34399999999857E-05 |
| Normal-vs-N1 |
1.190960E-01 |
| N0-vs-N1 |
8.079200E-01 |
|
|
